NewAmsterdam Pharma CSO Johannes Jacob Pieter Kastelein reports $1,257,659 share disposal

Bitget2026/10/02 20:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NewAmsterdam Pharma Chief Scientific Officer Johannes Jacob Pieter Kastelein cut indirect ordinary share holdings to 69,302 on Sept. 30, 2026.
Disposed of 50,246 ordinary shares at a weighted average price of $ 25.03.
The sale followed the acquisition of 50,246 ordinary shares via option exercise in the same session.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-412431), on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NewAmsterdam Pharma CSO Johannes Jacob Pieter Kastelein reports $1,257,659 share disposal

You may also like

Crypto prices